Overweight patients given an experimental weight loss drug being developed by China's Sciwind Biosciences lost an average of ...

While the makers of Ozempic have stated that its GLP-1 medication was not made to be used as a weight loss drug, nor should ...

Novo Nordisk A/S’s next-generation obesity shot CagriSema helped patients lose weight in large studies despite only about three-quarters of the patients ever making it to the highest dose.

A trial pitting weight loss jab Mounjaro against competitor Wegovy ended with one clear winner, and Mounjaro is getting ...

Ozempic is an FDA-approved medication for people with type 2 diabetes. It’s often prescribed off-label for weight loss — that ...

Some new medications in development are also trying to solve for a persistent side effect of existing drugs: Patients who ...

A new study reports that people taking GLP-1 drugs in daily life don’t lose as much weight as those in clinical trials who ...

A novel weight loss drug in the same class as semaglutide has successfully met its targets in its largest clinical trial yet, ...

An early study have found that people who received higher doses of amycretin as a weekly jab lost 24.3% of their body weight ...

A new study found that weight-loss medications like Ozempic and Mounjaro are not as effective in a “real-world” setting ...

This would make amycretin a more effective than other weight loss drugs like Wegovy, where a trial found that patients lost ...

A small, early-stage study published in the journal Headache suggested a diabetes drug may ease migraines by lowering ...